Immune & Thymic · Research deep dive
VIP: the cited literature
Every study referenced in the VIP monograph, with plain-language context, PubMed links to read each paper yourself, and how the compound appears in the dosing literature.
How this compound is studied
Across the dosing literature, VIP is studied at 50 mcg – 100 mcg per administration, typically one to four times daily (intranasal in most protocols). The reference walkthrough below maps each citation to what it actually showed.
References covered
Vasoactive intestinal peptide: biology and therapeutic potential
Pharmacol. Rev., 2004
The full walkthrough is for subscribers
Unlock the evidence grading, what each study actually found, how the trials dosed it, reported safety signals, open questions, and PubMed links for VIP.